Conversion to sirolimus after kidney and liver transplantation: indications and outcomes

Transplant Proc. 2003 Mar;35(2):791. doi: 10.1016/s0041-1345(03)00046-0.

Authors

L Wramner¹, G Norden, G Herlenius, S Friman, M Olausson, L Bäckman

Affiliation

¹ Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden. lars.wramner@spray.se

PMID: 12644139
DOI: 10.1016/s0041-1345(03)00046-0

No abstract available

MeSH terms

Adult
Aged
Humans
Immunosuppressive Agents / adverse effects
Immunosuppressive Agents / therapeutic use*
Liver Transplantation / immunology*
Liver Transplantation / pathology
Middle Aged
Sirolimus / adverse effects
Sirolimus / therapeutic use*
Treatment Outcome

Substances

Immunosuppressive Agents
Sirolimus